Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP6V1G1P3 is classified as a pseudogene derived from the gene encoding ATPase H+ transporting V1 subunit G1. Pseudogenes are DNA sequences similar to functional genes but lack protein-coding ability due to accumulating mutations and genetic drift. Some pseudogenes can be transcribed into non-coding RNAs and, in rare cases, may have regulatory roles, such as acting as RNA decoys or sources of small interfering RNAs[1][2][4]. However, there_is_currently_no_data_supporting_any_functional, clinical, or therapeutic relevance for ATP6V1G1P3 itself[8][7][3]. If you need structured data on a functional H+ transporting ATPase, you should look for the canonical, protein-coding genes such as **ATP6V1G1** (without the P3 suffix), which are legitimate subunits of the vacuolar ATPase complex and bona fide drug targets in some contexts[3][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATPase H+ transporting V1 subunit G1 pseudogene 3 (ATP6V1G1P3).